Athira PharmaÂ Inc (ATHA) Financials

$7.66

$0.75 (10.85%)

As on 13-Mar-2026 09:30EDT

Market cap

$27 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	68.09	0.97	0.97	1.05	0.48	2.00
Gross Profit	-68.09	-0.97	-0.97	-1.05	-0.48	-2.00
Operating Expenses	34.18	100.90	125.47	104.02	63.54	18.00
Operating Profit (EBIT)	-102.27	-100.90	-125.47	-104.02	-64.02	-20.00
Other Income	--	--	--	3.22	0.33	-1.28
Profit before Tax	-105.61	-96.94	-117.67	-95.64	-54.85	-19.96
Provision for Tax	--	--	-1.63	-8.38	-0.48	-1.32
Profit after Tax (Net Income)	-105.61	-96.94	-117.67	-95.64	-54.85	-19.96
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-95.64	-54.85	-19.99

Liabilities ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	27.79	44.84	130.19	235.14	321.08	274.28
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	16.86	0.80	1.22	1.59	1.63	0.88
Current Liabilities	47.50	13.14	28.84	21.43	9.29	4.41
Total Liabilities	92.15	58.78	160.25	258.15	332.01	279.56

Assets ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	2.69	3.94	5.52	50.62	71.21	87.23
Current Assets	89.46	54.84	154.73	207.53	260.80	192.34
Total Assets	92.15	58.78	160.25	258.15	332.01	279.56
Total Debt*	0.80	1.22	1.59	1.91	1.92	1.00
Net Current Assets	--	41.71	125.89	186.10	251.51	187.93

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-45.73	-97.17	-100.75	-72.47	-43.10	-24.11
Cash Flow from Investing Activities	-15.89	54.83	95.09	57.66	-4.08	-210.07
Cash from Financing Activities	82.46	0.19	0.49	0.65	97.09	292.75
Net Cash Inflow / Outflow	--	--	--	-14.15	49.91	58.57

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-24.70	-25.19	-30.88	-25.29	-14.67	-6.14
Cash EPS ($)	-24.70	-24.94	-30.62	-25.07	-14.55	-6.14
Adjusted Book Value ($)	6.50	11.65	34.16	62.17	85.90	84.43
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-10.69	-25.25	-26.44	-19.16	-11.53	-7.42
Free Cash Flow per Share ($)	-10.69	-25.26	-26.52	-19.46	-11.95	-8.14

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-282.94	-109.02	-63.81	-34.15	-18.34	-15.52
ROE (%)	-290.81	-110.77	-64.42	-34.39	-18.43	-15.68
ROA (%)	-139.94	-88.52	-56.25	-32.41	-17.94	-14.16
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	-2,973.85	-16,423.05	1,557.77
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	23.76	-42.86	-62.00	-180.02	-306.81
Net Profit Growth (%)	-8.94	17.62	-23.04	-74.36	-174.88	-286.65
EPS Growth (%)	0.02	0.18	-0.22	-0.72	-1.39	-2.88
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	-0.31	-0.02	-0.08	-0.13	-0.89	-5.58
Price / Book Value	1.16	0.05	0.07	0.05	0.15	0.41
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.54	0.50	1.08	2.12	3.74	3.70
Close Price ($)	7.57	5.87	24.30	31.70	130.30	342.50
High Price ($)	8.36	42.98	44.10	142.20	342.50	347.90
Low Price ($)	2.20	4.12	13.30	25.30	88.80	157.90
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	0.03	0.03	0.01	0.01	0.01	0.00
Short term debt to equity ratio	0.02	0.01	0.00	0.00	0.00	0.00
Current Ratio	1.88	4.18	5.37	9.68	28.07	43.66
Quick Ratio	--	--	--	9.74	28.32	43.96
Interest Coverage	--	--	--	-3.65	-18,283.33	-53.37

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	-462.50	-620.89	-1,386.27	-237.41
Payable days	13.16	84.35	495.67	534.63	657.68	144.18
Cash Conversion Cycle	--	--	--	--	--	--